FDA Panel Recommends Vaginal Mesh Studies and Reclassification

On September 8, 2011, the U.S. Food and Drug Administration (“FDA”) Obstetrics and Gynecology Devices advisory panel met to discuss transvaginal mesh products which are often used to treat those with pelvic organ prolapse (POP). The panel met in response to an FDA recommendation, issued on July 12, 2011, that found "clear risks associated with [...]